Treatment of Persistent Phenothiazine-Induced Oral Dyskinesia

¹ Assistant Professor, Department of Psychiatry, University of Alberta Hospital, Edmonton 61, Alberta, Canada.

A comparison of the features of persistent oral dyskinesia and functional oral movements is made. The literature on the drug control of oral dyskinesia is reviewed. In a double-blind interrupted cross-over trial in two established cases of oral dyskinesia, thiopropazate dihydrochloride was found to be highly effective.

This article has been cited by other articles:

				D. V. Jeste and R. Jed Wyatt Therapeutic Strategies Against Tardive Dyskinesia: Two Decades of Experience Arch Gen Psychiatry, July 1, 1982; 39(7): 803 - 816. [Abstract] [PDF]

				G. Gardos, J. O. Cole, and R. La Brie The Assessment of Tardive Dyskinesia Arch Gen Psychiatry, October 1, 1977; 34(10): 1206 - 1212. [Abstract] [PDF]

				H. Pakkenberg and R. Fog Spontaneous Oral Dyskinesia: Results of Treatment With Tetrabenazine, Pimozide, or Both Arch Neurol, November 1, 1974; 31(5): 352 - 353. [Abstract] [PDF]

				H. Kazamatsuri, C.-p. Chien, and J. O. Cole Treatment of Tardive Dyskinesia: III. Clinical Efficacy of a Dopamine Competing Agent, Methyldopa Arch Gen Psychiatry, December 1, 1972; 27(6): 824 - 827. [Abstract] [PDF]

				H. Kazamatsuri, C.-p. Chien, and J. O. Cole Therapeutic Approaches to Tardive Dyskinesia: A Review of the Literature Arch Gen Psychiatry, October 1, 1972; 27(4): 491 - 499. [Abstract] [PDF]

				H. Kazamatsuri, C.-p. Chien, and J. O. Cole Treatment of Tardive Dyskinesia: I. Clinical Efficacy of a Dopamine-Depleting Agent, Tetrabenazine Arch Gen Psychiatry, July 1, 1972; 27(1): 95 - 99. [Abstract] [PDF]

				H. Kazamatsuri, C.-p. Chien, and J. O. Cole Treatment of Tardive Dyskinesia: II. Short-Term Efficacy of Dopamine-Blocking Agents Haloperidol and Thiopropazate Arch Gen Psychiatry, July 1, 1972; 27(1): 100 - 103. [Abstract] [PDF]